Your browser doesn't support javascript.
loading
Phosphorylation of hTERT at threonine 249 is a novel tumor biomarker of aggressive cancer with poor prognosis in multiple organs.
Matsuda, Yoko; Yamashita, Taro; Ye, Juanjuan; Yasukawa, Mami; Yamakawa, Keiko; Mukai, Yuri; Machitani, Mitsuhiro; Daigo, Yataro; Miyagi, Yohei; Yokose, Tomoyuki; Oshima, Takashi; Ito, Hiroyuki; Morinaga, Soichiro; Kishida, Takeshi; Minamoto, Toshinari; Yamada, Shinji; Takei, Junko; Kaneko, Mika K; Kojima, Motohiro; Kaneko, Shuichi; Masaki, Tsutomu; Hirata, Masahiro; Haba, Reiji; Kontani, Keiichi; Kanaji, Nobuhiro; Miyatake, Nobuyuki; Okano, Keiichi; Kato, Yukinari; Masutomi, Kenkichi.
Afiliação
  • Matsuda Y; Oncology Pathology, Department of Pathology and Host-Defense, Faculty of Medicine, Kagawa University, Kita-gun, Japan.
  • Yamashita T; Department of Gastroenterology, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Japan.
  • Ye J; Oncology Pathology, Department of Pathology and Host-Defense, Faculty of Medicine, Kagawa University, Kita-gun, Japan.
  • Yasukawa M; Division of Cancer Stem Cell, National Cancer Center Research Institute, Tokyo, Japan.
  • Yamakawa K; Oncology Pathology, Department of Pathology and Host-Defense, Faculty of Medicine, Kagawa University, Kita-gun, Japan.
  • Mukai Y; Oncology Pathology, Department of Pathology and Host-Defense, Faculty of Medicine, Kagawa University, Kita-gun, Japan.
  • Machitani M; Division of Cancer Stem Cell, National Cancer Center Research Institute, Tokyo, Japan.
  • Daigo Y; Department of Medical Oncology and Cancer Center, Shiga University of Medical Science, Otsu, Japan.
  • Miyagi Y; Center for Advanced Medicine against Cancer, Shiga University of Medical Science, Otsu, Japan.
  • Yokose T; Center for Antibody and Vaccine Therapy, Research Hospital, Institute of Medical Science Hospital, The University of Tokyo, Tokyo, Japan.
  • Oshima T; Kanagawa Cancer Center Research Institute, Yokohama, Japan.
  • Ito H; Department of Pathology, Kanagawa Cancer Center, Yokohama, Japan.
  • Morinaga S; Department of Gastrointestinal Surgery, Kanagawa Cancer Center, Yokohama, Japan.
  • Kishida T; Department of Thoracic Surgery, Kanagawa Cancer Center, Yokohama, Japan.
  • Minamoto T; Department of Hepato-Biliary and Pancreatic Surgery, Kanagawa Cancer Center, Yokohama, Japan.
  • Yamada S; Department of Urology, Kanagawa Cancer Center, Yokohama, Japan.
  • Takei J; Division of Translational and Clinical Oncology, Cancer Research Institute, Kanazawa University, Kanazawa, Japan.
  • Kaneko MK; Department of Antibody Drug Development, Tohoku University Graduate School of Medicine, Sendai, Japan.
  • Kojima M; Department of Antibody Drug Development, Tohoku University Graduate School of Medicine, Sendai, Japan.
  • Kaneko S; Department of Antibody Drug Development, Tohoku University Graduate School of Medicine, Sendai, Japan.
  • Masaki T; Division of Pathology, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Chiba, Japan.
  • Hirata M; Department of Gastroenterology, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Japan.
  • Haba R; Department of Gastroenterology and Neurology, Faculty of Medicine, Kagawa University, Kita-gun, Japan.
  • Kontani K; Department of Gastroenterology and Neurology, Faculty of Medicine, Kagawa University, Kita-gun, Japan.
  • Kanaji N; Diagnostic Pathology, Faculty of Medicine, Kagawa University, Kita-gun, Japan.
  • Miyatake N; Department of Thoracic, Breast and Endocrine Surgery, Faculty of Medicine, Kagawa University, Kita-gun, Japan.
  • Okano K; Department of Internal Medicine, Division of Hematology, Rheumatology and Respiratory Medicine, Faculty of Medicine, Kagawa University, Kita-gun, Japan.
  • Kato Y; Department of Hygiene, Faculty of Medicine, Kagawa University, Kita-gun, Japan.
  • Masutomi K; Department of Gastroenterological Surgery, Faculty of Medicine, Kagawa University, Kita-gun, Japan.
J Pathol ; 257(2): 172-185, 2022 06.
Article em En | MEDLINE | ID: mdl-35094384

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Telomerase / Neoplasias Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Telomerase / Neoplasias Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article